227PEvaluation of the MammaTyper® as a molecular predictor for pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) and outcome in patients with different breast cancer (BC) subtypes. (23rd October 2018) - Fasching, P A; Laible, M; Weber, K E; Wirtz, R M; Denkert, C; Schlombs, K; Schmatloch, S; Camara, O; Lück, H J; Huober, J; Karn, T; van Mackelenbergh, M T; et al.